Innovative Product Launches Sakura Finetek Europe has recently launched advanced pathology solutions such as the Tissue-Tek xPrint LP Laser Cassette Printer and Tissue-Tek Genie staining system, indicating a strong focus on innovation and new product adoption, presenting opportunities for upselling complementary accessories or service contracts.
Strategic Partnerships The company's collaboration with NexInfo Solutions to implement Oracle Cloud ERP and CX Applications demonstrates an openness to enterprise digital transformation initiatives, suggesting potential sales of ERP, cloud services, and integrated lab management solutions.
Leadership & Growth Recent leadership changes, including the appointment of a new President and General Manager, reflect a strategic focus on expanding market presence and strengthening customer relationships, which could open doors for targeted engagement and strategic account development.
Technology Integration Sakura’s usage of advanced tech stacks including Oracle ERP Cloud and Fusion coupled with automation solutions highlights an emphasis on operational efficiency, creating opportunities to offer tailored enterprise solutions and enhance laboratory workflow automation.
Market Positioning Operating within a competitive landscape with companies like Leica Biosystems and Thermo Fisher Scientific, Sakura can leverage its innovative product range and recent technological partnerships to position itself distinctly in the pathology laboratory equipment market and explore expansion opportunities in emerging healthcare markets.
$1B$10B
$1B$10B
$10B
$250M$500M
$10B
$10B
$1B$10B
$10B
$1B$10BSakura Finetek Europe B.V. uses 8 technology products and services including Open Graph, TimeXtender, jQuery, and more. Explore Sakura Finetek Europe B.V.'s tech stack below.
| Sakura Finetek Europe B.V. Email Formats | Percentage |
| FLast@sakuraus.com | 76% |
| First.Last@sakuraus.com | 18% |
| FMiddleLast@sakuraus.com | 2% |
| F.Last@sakuraus.com | 1% |
| LF@sakuraus.com | 1% |
| FirstL@sakuraus.com | 1% |
| Last@sakuraus.com | 1% |
| F.Last@sakura.eu | 93% |
| First.Last@sakura.eu | 3% |
| Last@sakura.eu | 3% |
| FLast@sakura.eu | 1% |
Medical Equipment ManufacturingSouth Holland, Netherlands201-500 Employees
Empowering pathologists and lab technicians worldwide. When it comes to diagnosing cancer, there’s no time to wait. At Sakura we’re driven by our desire to advance cancer diagnosis through fully automated anatomic pathology. Our Mission: Advancing cancer diagnoses by providing integrated solutions for anatomic pathology and patients through best-in-class innovation, quality and customer care.
Company Overview
Media & News
Funding & FinancialsSakura Finetek Europe B.V.'s revenue is estimated to be in the range of $10M$25M
Funding & FinancialsSakura Finetek Europe B.V.'s revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com